910463-68-2
C187H291N45O59
4113.57754
99% min (HPLC)
White powder
Antidiabetic, anti-obesity
Semaglutide
2/17/2041 (Semaglutide)
GLP-1
N
DMF to be obtained by the end of December 2024
PIC/S GMP (China, US and Europe)
Availability: | |
---|---|
Product Description
We offer semaglutide API from both fermentation and synthesis.
About the Manufacturer
The manufacturer strictly follows GMP standard, and has 32 laboratories, 5 API production lines, and 6 injection production line.
In 2023, the PFS & Cartridge injection line was inspected by US FDA.